4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001062993-15-003576
CIK 0000875622operating
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 5:02 PM ET
Size
20.1 KB
Accession
0001062993-15-003576
Insider Transaction Report
Form 4
Gitman Paul
Director
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2015-06-23$26.43/sh+15,000$396,450→ 73,133 total - Sale
Common Stock, $0.001 par value
2015-06-23$50.95/sh−15,000$764,310→ 51,825 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-06-23−15,000→ 0 totalExercise: $20.00Exp: 2018-09-07→ Common Stock, $0.001 par value (15,000 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2015-06-23$13.60/sh+6,308$85,789→ 58,133 total - Sale
Common Stock, $0.001 par value
2015-06-23$53.59/sh−6,308$338,018→ 81,825 total - Exercise/Conversion
Common Stock, $0.001 par value
2015-06-23$20.00/sh+15,000$300,000→ 88,133 total - Sale
Common Stock, $0.001 par value
2015-06-23$51.84/sh−15,000$777,585→ 66,825 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-06-23−15,000→ 0 totalExercise: $26.43Exp: 2019-09-07→ Common Stock, $0.001 par value (15,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2015-06-23−6,308→ 8,692 totalExercise: $13.60Exp: 2018-06-09→ Common Stock, $0.001 par value (6,308 underlying)
Footnotes (7)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2015.
- [F2]The selling price of $53.5856 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $53.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The selling price of $51.8390 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The selling price of $50.9540 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]The option was granted on June 10, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
- [F6]The option was granted on September 8, 2009 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
- [F7]The option was granted on September 8, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 5:02 PM ET
- Size
- 20.1 KB